Inside Nephrology: A Weekly Review
Nefrologia
Nephrology Updates: From COVID Complications to Kidney Stone Management
This week's nephrology update covers COVID-related rhabdomyolysis, renal cell carcinoma therapies, vaginal microbiome impacts on UTIs, pregnancy in ESKD, apoptotic bodies in kidney disease, nanomedicine approaches, hyponatraemia guidelines, kidney stone management, critical care nephrology, and KDIGO anemia guidelines.
Accedi o Registrati per ascoltare questo episodio
Bibliografia
1. Rhabdomyolysis After COVID-19.
Authors: Kataria N, Devadass A, Sundac L, et al.
Journal: The Medical journal of Australia
PMID: 42444406
DOI: 10.5694/mja2.70247
2. Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: final analysis of efficacy and safety from the phase III CheckMate 214 trial.
Authors: Choueiri TK, Albigès L, McDermott DF, et al.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
PMID: 41786248
DOI: 10.1016/j.annonc.2026.02.017
3. Mesenchymal/stromal cell therapy in kidney diseases: an update.
Authors: Navez M, Detry O, Jouret F
Journal: Current opinion in nephrology and hypertension
PMID: 41925211
DOI: 10.1097/MNH.0000000000001184
4. The Vaginal Microbiome and Recurrent and Chronic Urinary Tract Infection.
Authors: Dalby KL, Horsley H, Spratt D, et al.
Journal: International urogynecology journal
PMID: 41359046
DOI: 10.1007/s00192-025-06434-1
5. Dialysis and Pregnancy: Optimizing Therapy for Best Maternal and Fetal Outcomes.
Authors: Mangalgi S, Shah S
Journal: Hemodialysis international. International Symposium on Home Hemodialysis
PMID: 41795224
DOI: 10.1111/hdi.70062
6. The prostatic acid phosphatase in prostate cancer: A novel theranostic target.
Authors: Seifert KE, Reimann J, Rust M, et al.
Journal: Seminars in nuclear medicine
PMID: 41925410
DOI: 10.1053/j.semnuclmed.2026.03.004
7. Apoptotic Bodies in Kidney Disease: Orchestrators of Inflammation, Fibrosis, and Repair.
Authors: Cozzolino M, Ciceri P
Journal: Journal of the American Society of Nephrology : JASN
PMID: 41774507
DOI: 10.1681/ASN.0000001073
8. Intravesical therapy for recurrent urinary tract infection: a systematic review and meta-analysis.
Authors: Kwon M, Ahmad A, Lott N, et al.
Journal: BJU international
PMID: 41858162
DOI: 10.1111/bju.70252
9. RAAS blockade in the kidney life-cycle-treatment standard.
Authors: Moriconi D, Garcia-Carro C, Nuñez J, et al.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
PMID: 42008148
DOI: 10.1093/ndt/gfag090
10. Nanomedicine-based sensitization and resistance reversal in immunotherapy of clear cell renal cell carcinoma: from tumor microenvironment to precision delivery.
Authors: Ma J, Qiang Z, Xie W, et al.
Journal: Medical oncology (Northwood, London, England)
PMID: 42397660
DOI: 10.1007/s12032-026-03331-5
Authors: Kataria N, Devadass A, Sundac L, et al.
Journal: The Medical journal of Australia
PMID: 42444406
DOI: 10.5694/mja2.70247
2. Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: final analysis of efficacy and safety from the phase III CheckMate 214 trial.
Authors: Choueiri TK, Albigès L, McDermott DF, et al.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
PMID: 41786248
DOI: 10.1016/j.annonc.2026.02.017
3. Mesenchymal/stromal cell therapy in kidney diseases: an update.
Authors: Navez M, Detry O, Jouret F
Journal: Current opinion in nephrology and hypertension
PMID: 41925211
DOI: 10.1097/MNH.0000000000001184
4. The Vaginal Microbiome and Recurrent and Chronic Urinary Tract Infection.
Authors: Dalby KL, Horsley H, Spratt D, et al.
Journal: International urogynecology journal
PMID: 41359046
DOI: 10.1007/s00192-025-06434-1
5. Dialysis and Pregnancy: Optimizing Therapy for Best Maternal and Fetal Outcomes.
Authors: Mangalgi S, Shah S
Journal: Hemodialysis international. International Symposium on Home Hemodialysis
PMID: 41795224
DOI: 10.1111/hdi.70062
6. The prostatic acid phosphatase in prostate cancer: A novel theranostic target.
Authors: Seifert KE, Reimann J, Rust M, et al.
Journal: Seminars in nuclear medicine
PMID: 41925410
DOI: 10.1053/j.semnuclmed.2026.03.004
7. Apoptotic Bodies in Kidney Disease: Orchestrators of Inflammation, Fibrosis, and Repair.
Authors: Cozzolino M, Ciceri P
Journal: Journal of the American Society of Nephrology : JASN
PMID: 41774507
DOI: 10.1681/ASN.0000001073
8. Intravesical therapy for recurrent urinary tract infection: a systematic review and meta-analysis.
Authors: Kwon M, Ahmad A, Lott N, et al.
Journal: BJU international
PMID: 41858162
DOI: 10.1111/bju.70252
9. RAAS blockade in the kidney life-cycle-treatment standard.
Authors: Moriconi D, Garcia-Carro C, Nuñez J, et al.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
PMID: 42008148
DOI: 10.1093/ndt/gfag090
10. Nanomedicine-based sensitization and resistance reversal in immunotherapy of clear cell renal cell carcinoma: from tumor microenvironment to precision delivery.
Authors: Ma J, Qiang Z, Xie W, et al.
Journal: Medical oncology (Northwood, London, England)
PMID: 42397660
DOI: 10.1007/s12032-026-03331-5
